Occupational risk factors

Scandinavian Journal of Urology and Nephrology

Volumn 42, Issue SUPPL.218, 2008, Pages 58-63

  Delclos, George L ^a   Lerner, Seth P ^b  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Bladder cancer; Carcinogen; Occupation; Risk factor

Indexed keywords

CARCINOGEN;

BLADDER CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENICITY; CONFERENCE PAPER; DEVELOPING COUNTRY; HUMAN; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; PRIORITY JOURNAL; WORKPLACE; BLADDER TUMOR; HEALTH; MORBIDITY; OCCUPATIONAL DISEASE; REVIEW;

HUMANS; MORBIDITY; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; URINARY BLADDER NEOPLASMS; WORLD HEALTH;

EID: 52949122547     PISSN: 00365599     EISSN: 16512065     Source Type: Journal    
DOI: 10.1080/03008880802284423     Document Type: Conference Paper

References (53)

1. Rehn L. Blasengeschwuelste bei Fuchsinarbeitern. Arch Klin Chur 1895;50:588-600.
2. Weisburger JH. Comments on the history and importance of aromatic and heterocyclic amines in public health. Mutat Res 2002;506-507:9-20.
3. Hueper WC, Wiley F, Wolfe HD. Experimental production of bladder tumors in dogs by administration of (-naphthylamine. J Ind Hyg Toxicol 1938;20:46-84.
4. Case RAM, Hosler ME. Tumours of the urinary bladder in workmen engaged in the manufacture and use of certain dyestuff intermediates in the British chemical industry. Part 1, the role of aniline, benzidine, 1-naphthylamine and 2-naphthylamine. Br J Ind Med 1954;11:75-104.
5. Case RAM, Pearson JT. Tumours of the urinary bladder in workmen engaged in the manufacture and use of certain dyestuff intermediates in the British chemical industry. Part II. Further considerations of the role of aniline and of the manufacture of auramine and magenta (fuchsin) as possible causative agents. Br J Ind Med 1954;11:213-6.
6. Verma DK, Purdham JT, Roels HA. Translating evidence about occupational conditions into strategies for prevention. Occup Environ Med 2002;59:205-14.
7. Yu MC, Skipper PL, Tannenbaum SR, Chan KK, Ross RK. Arylamine exposures and bladder cancer risk. Mutat Res 2002;506-507:21-8.
8. Vineis P, Piratsu R. Aromatic amines and cancer. Cancer Causes Control 1997;8:346-55.
9. Hemstreet GP, Yin S, Ma Z, Bonner RB, Bi W, Rao JY, et al. Biomarker risk assessment and bladder cancer detection in a cohort exposed to benzidine. J Natl Cancer Inst 2001;93:427-36.
10. Delclós J, Betancourt O, Marqués F, Tovalín H. Globalización y salud laboral. Arch Prev Riesgos Labor 2003;6:4-9.
11. Yaris F, Dikici MF, Sabuncu HH, Yaris E. A case-control study on the etiology of urinary bladder cancer in Istanbul, Turkey. Asian Pacific J Cancer Prev 2006;7:591-4.
12. Ruder AM, Fine LJ, Smith DS. National estimates of occupational exposure to animal bladder tumorigens. J Occup Med 1990;32:797-805.
13. International Agency for Research on Cancer. Overall evaluation of carcinogenicity to humans. Group 1: carcinogenic to humans [online]. Updated March 2008 [cited April 20, 2008]. Available from: http:/monographs.iarc.fr/ENG/ Classification/crthgr01.php
14. International Agency for Research on Cancer. Overall evaluation of carcinogenicity to humans. Group 2A, 2B: probable or possibly carcinogenic to humans [online]. Updated March 2008 [cited April 20, 2008]. Available from: http:/monographs.iarc.fr/ENG/Classification/crthgr01.php
15. Dryson E, 't Mannetje A, Walls C, McLean D, McKenzie F, Maule M, et al. Case-control study of high risk occupations for bladder cancer in New Zealand. Int J Cancer 2008;122:1340-6.
16. Negri E, La Vecchia C. Epidemiology and prevention of bladder cancer. Eur J Cancer Prev 2001;10:7-14.
17. Monson R, Christiani D. Summary of the evidence: occupation and environment and cancer. Cancer Causes Control 1997;8:529-31.
18. Thériault G, Tremblay C, Cordier S, Gingras S. Bladder cancer in the aluminium industry. Lancet 1984;1:947-50.
19. Gibbs GW. Mortality of aluminum reduction plant workers, 1950 through 1977. J Occup Med 1985;27:761-70.
20. Colt JS, Baris D, Stewart P, Schned AR, Heaney JA, Mott LA, et al. Occupation and bladder cancer risk in a population-based case-control study in New Hampshire. Cancer Causes Control 2004;15:759-69.
21. Boffetta P, Dosemeci M, Gridley G, Bath H, Moradi T, Silverman D. Occupational exposure to diesel engine emissions and risk of cancer in Swedish men and women. Cancer Causes Control 2001;12:365-74.
22. Boffetta P, Silverman DT. A meta-analysis of bladder cancer and diesel exhaust exposure. Epidemiology 2001;12:125-30.
23. Gun RT, Pratt NL, Griffith EC, Adams GG, Bisby JA, Robinson KL. Update of a prospective study of mortality and cancer incidence in the Australian petroleum industry. Occup Environ Med 2004;61:150-6.
24. Gun RT, Pratt N, Ryan P, Roder D. Update of mortality and cancer incidence in the Australian petroleum industry cohort. Occup Environ Med 2006;63:476-81.
25. Lewis RJ, Schnatter AR, Drummond I, Murray N, Thompson FS, Katz AM, et al. Mortality and cancer morbidity in a cohort of Canadian petroleum workers. Occup Environ Med 2003;60:918-28.
26. Blair A, Stewart PA, Zaebst DD, Pottern L, Zey JN, Bloom TF, et al. Mortality of industrial workers exposed to acrylonitrile. Scand J Work Environ Health 1998;24(Suppl 2): 25-41.
27. Marsh GM, Gula MH, Youk AO, Cassidy LD. Bladder cancer among chemical workers exposed to nitrogen products and other substances. Am J Ind Med 2002;42:286-95.
28. Collins JJ, Acquavella JF. Review and meta-analysis of studies of acrylonitrile workers. Scand J Work Environ Health 1998;24(Suppl 2):71-80.
29. Gaertner RR, Theriault GP. Risk of bladder cancer in foundry workers: a meta-analysis. Occup Environ Med 2002;59:655-63.
30. Rafnsson V, Sulem P. Cancer incidence among marine engineers, a population-based study (Iceland). Cancer Causes Control 2003;14:29-35.
31. Marsh GM, Callahan C, Pavlock D, Leviton LC, Talbott EO, Hemstreet G. A protocol for bladder cancer screening and medical surveillance among high-risk groups: the Drake Health Registry experience. J Occup Med 1990;32:881-6.
32. Felknor SA, Delclos GL, Lerner SP, Burau KD, Wood SM, Lusk CM, et al. Bladder cancer screening program for a petrochemical cohort with potential exposure to bnapthylamine. J Occup Environ Med 2003;45:289-94.
33. Hemstreet GP III, Yin S, Ma Z, Bonner RB, Bi W, Rao JY, et al. Biomarker risk assessment and bladder cancer detection in a cohort exposed to benzidine. J Natl Cancer Inst 2001;93:427-36.
34. Carpenter L, Roman E. Cancer and occupation in women: identifying associations using routinely collected national data. Environ Health Perspect 1999;107(Suppl):299-303.
35. Ji J, Granstrom C, Hemminki K. Occupation and bladder cancer: a cohort study in Sweden. Br J Cancer 2005;92:1276-8.
36. Pelucchi C, La Vecchia C, Negri E, Dal Maso L, Franceschi S. Smoking and other risk factors for bladder cancer in women. Prev Med 2002;35:114-20.
37. Zheng T, Cantor KP, Zhang Y, Lynch CF. Occupation and bladder cancer: a population-based, case-control study in Iowa. J Occup Environ Med 2002;44:685-91.
38. Silverman DT, Levin LI, Hoover RN, Hartage P. Occupational risks of bladder cancer in the United States. I. White men. J Natl Cancer Inst 1989;81:1472-80.
39. Silverman DT, Levin LI, Hoover RN. Occupational risks of bladder cancer in the United States. II. Nonwhite men. J Natl Cancer Inst 1989;81:1480-3.
40. Schulz MR, Loomis D. Occupational bladder cancer mortality among racial and ethnic minorities in 21 states. Am J Ind Med 2000;38:90-8.
41. Cohen SM, Shirai T, Steineck G. Epidemiology and etiology of premalignant and malignant urothelial changes. Scand J Urol Nephrol 2000:205(Suppl):105-15.
42. Cartwright RA, Gadian T, Garland JB, Bernard SM. The influence of malignant cell cytology on the survival of industrial bladder cancer cases. J Epidemiol Community Health 1981;35:35-8.
43. Shinka T, Sawada Y, Morimoto S, Fujinaga T, Nakamura J, Ohkawa T. Clinical study on urothelial tumors of dye workers in Wakayama City. J Urol 1991;146:1504-7.
44. Vineis P, Simonato L. Proportion of lung and bladder cancers in males resulting from occupation: a systematic approach. Arch Environ Health 1991;46:6-15.
45. Barone-Adesi F, Richiardi L, Merletti F. Population attributable risk for occupational cancer in Italy. Int J Occup Environ Health 2005;11:23-31.
46. Sorahan T, Hamilton L, Jackson JR. A further cohort study of workers employed at a factory manufacturing chemicals for the rubber industry, with special reference to the chemicals 2-mercaptobenzothiazole (MBT), aniline, phenyl-β-naphthylamine and o-toluidine. Occup Environ Med 2000;57:106-15.
47. Miyakawa M, Tachibana M, Miyakawa A. Re-evaluation of the latent period of bladder cancer in dyestuff-plant workers in Japan. Int J Urol 2001;8:423-30.
48. Vineis P, Marinelli D, Autrup H, Brockmoller J, Cascorbi I, Daly AK, et al. Current smoking, occupation, N-acetyltransferase-2 and bladder cancer: a pooled analysis of genotype-based studies. Cancer Epidemiol Biomarkers Prev 2001;10:1249-52.
49. Vineis P, Landi MT, Caporaso N. Metabolic polymorphisms and the cancer risk: the evaluation of epidemiological studies. Medicina del Lavoro 1992;83:557-75.
50. Vineis P, Caporaso N, Cuzick J, Lang M, Malats N, Boffetta P. Genetic susceptibility to cancer: metabolic polymorphisms. IARC Scientific Publ No 148. Lyon: IARC; 1999.
51. Cascorbi I, Roots I, Brockmuller J. Association of NAT1 and NAT2 polymorphisms to urinary bladder cancer: significantly reduced risk in subjects with NAT1 x 10. Cancer Res 2001;61:5051-6.
52. Shinka T, Ogura H, Morita T, Nishikawa T, Fujimaga T, Ohkawa T. Relationship between glutathione S-transferase M1 deficiency and urothelial cancer in dye workers exposed to aromatic amines. J Urol 1998;159:380-3.
53. Hung RJ, Boffetta P, Brennan P, Malaveille C, Hautefeuille A, Donato F, et al. GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population. Int J Cancer 2004;110:598-604.